SBI Life Insurance Company Analyst Review May 2026

This SBI Life Insurance Company analyst review for May 2026 covers the key data investors need for SBILIFE at its current price of Rs 1,700. SBI Life Insurance Company (NSE: SBILIFE) is India’s second largest private life insurer with a market capitalisation of approximately Rs 1,70,000 crore, leveraging the 22,000 plus SBI branch network for low-cost bancassurance distribution. The analyst consensus target of Rs 1,900 implies meaningful upside from current levels, and this article examines the technical levels, business performance, valuation, and key risks that will determine whether SBILIFE achieves that target through FY27.

Click Here – Get Free Investment Predictions

SBI Life Insurance Company Company Snapshot May 2026

SBI Life’s bancassurance model through SBI branches provides the lowest cost of distribution in Indian life insurance. VNB margin above 28 percent and new business premium growth above 15 percent YoY make it one of the most efficient private life insurers. The table below summarises the key data referenced in this SBI Life Insurance Company analyst review.

Parameter	Value
NSE Ticker	SBILIFE
Sector	Life Insurance
CMP (May 2026)	Rs 1,700
52 Week High	Rs 2,054
52 Week Low	Rs 1,340
Market Cap	Rs 1,70,000 Crore
Trailing P/E	65.00x
Analyst Consensus Target	Rs 1,900
Bull Case Target	Rs 2,200
Bear Case Target	Rs 1,400

Analyst Insight in This SBI Life Insurance Company Analyst Review

Associate Director Kunal Singla suggests watching SBI Life Insurance Company closely in May 2026. At the current market price of Rs 1,700, Kunal Singla flags Life Insurance sector dynamics as a key driver for SBILIFE’s near-term price action. He notes support in the Rs 1,367 to Rs 1,615 zone and flags any sustained close above Rs 1,802 as a positive signal worth tracking. Kunal Singla’s perspective on SBI Life Insurance Company adds a layer of professional technical analysis to this SBI Life Insurance Company analyst review and is not a buy recommendation.

Technical Analysis in This SBI Life Insurance Company Analyst Review

At Rs 1,700, SBILIFE is trading within its 52-week band of Rs 1,340 to Rs 2,054. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.

Near-term support is identified in the Rs 1,367 to Rs 1,615 band while resistance is seen in the Rs 1,802 to Rs 1,800 zone. A sustained move above Rs 1,802 could open the path toward the analyst consensus of Rs 1,900.

Screen the best stocks on the Univest Screener.

Key Support and Resistance Levels

• Support Zone: Rs 1,367 to Rs 1,615 – investors tracking this SBI Life Insurance Company analyst review should watch for a stabilisation or bounce in this range as a potential accumulation signal.
• Resistance Zone: Rs 1,802 to Rs 1,800 – a sustained close above Rs 1,802 would be a positive breakout signal worth flagging.
• Medium-Term Target: The analyst consensus of Rs 1,900 represents the base-case upside for this SBI Life Insurance Company analyst review.

Business Segment Analysis

Individual Protection and Term Insurance

This is the primary revenue and margin driver for SBI Life Insurance Company, directly supporting the earnings trajectory toward the consensus target of Rs 1,900.

ULIPs (Unit Linked Insurance Plans)

This segment adds scale and diversification to SBI Life Insurance Company’s business model and is a meaningful EPS contributor through FY27 and FY28.

Group Life Insurance and Credit Life

This represents the medium-term growth frontier for SBI Life Insurance Company and a key re-rating catalyst for the stock over the next 12 to 24 months.

Valuation in This SBI Life Insurance Company Analyst Review

At Rs 1,700, SBI Life Insurance Company trades at a trailing P/E of 65.00x. This SBI Life Insurance Company analyst review presents three scenarios: a bull case of Rs 2,200 on strong earnings delivery, a base case of Rs 1,900 at consensus, and a bear case of Rs 1,400 if macro headwinds persist. Q1 FY27 results will be the first key validation point.

Scenario	Target Price	Key Condition
Bull Case	Rs 2,200	Strong earnings and sector tailwinds
Base Case (Consensus)	Rs 1,900	Moderate growth, analyst consensus estimate
Bear Case	Rs 1,400	Earnings miss or macro headwinds

Trade Outlook for SBI Life Insurance Company

Based on the technical and fundamental analysis in this SBI Life Insurance Company analyst review, investors might watch SBILIFE near the support zone of Rs 1,367 to Rs 1,615 for potential opportunities. A flag above Rs 1,802 could suggest improving momentum toward Rs 1,900. This article uses watch-and-flag language only and does not constitute a trade recommendation.

Key Risks for SBI Life Insurance Company in FY27

A well-rounded SBI Life Insurance Company analyst review must assess downside risks. Key risks for SBI Life Insurance Company include a macro slowdown affecting Life Insurance sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in SBILIFE.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Conclusion: SBI Life Insurance Company Analyst Review Verdict for 2026

This SBI Life Insurance Company analyst review concludes that at Rs 1,700, SBILIFE offers a defined risk-reward with a consensus target of Rs 1,900. The 52-week range of Rs 1,340 to Rs 2,054 provides context on the current entry point. Use this SBI Life Insurance Company analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on SBILIFE.

Frequently Asked Questions: SBI Life Insurance Company Analyst Review 2026

What is the analyst target for SBI Life Insurance Company in 2026?

The analyst consensus target is Rs 1,900, with a bull case of Rs 2,200 and a bear case of Rs 1,400. Monitor Q1 FY27 earnings for confirmation.

Is SBI Life Insurance Company a good investment at Rs 1,700?

At Rs 1,700 with a P/E of 65.00x and a consensus target of Rs 1,900, this SBI Life Insurance Company analyst review is constructive for medium to long-term investors in the Life Insurance sector. Always consult a SEBI-registered advisor before investing.

What is SBI Life Insurance Company’s 52-week high and low?

The 52-week high is Rs 2,054 and the 52-week low is Rs 1,340. At Rs 1,700, SBILIFE is positioned within this range as noted in this SBI Life Insurance Company analyst review.

What are the key risks for SBI Life Insurance Company?

Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Life Insurance sector.

Where can I get live data and analyst targets for SBI Life Insurance Company?

Track SBI Life Insurance Company’s live price and analyst targets on the Univest Screener alongside professional financial advice.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.